SCHEMBL26543790

SCHEMBL26543790

c1ccc(-c2cc(-c3ccccc3)nc(-n3c4ccccc4c4c5c6c7ccccc7c7c8ccccc8c8ccccc8c7c6n(-c6ccccc6)c5ccc43)n2)cc1

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
L3MBTL1 Q9Y468 5/20 0.36
KDM4E B2RXH2 3/20 0.36
ATM Q13315 2/20 0.36
KMT2A Q03164 4/20 0.33
MAPT P10636 4/20 0.33
MAPK1 P28482 4/20 0.33
MEN1 O00255 3/20 0.33
NPSR1 Q6W5P4 2/20 0.33
TSHR P16473 2/20 0.33
IL1R1 P14778 1/20 0.33
ALDH1A1 P00352 3/20 0.32
HTT P42858 3/20 0.32
HPGD P15428 3/20 0.32
SMN1; SMN2 Q16637 3/20 0.32
LMNA P02545 1/20 0.32
ADORA2A P29274 1/20 0.32
ADORA1 P30542 1/20 0.32
RXFP1 Q9HBX9 1/20 0.32
ACHE P22303 1/20 0.31
CASP1 P29466 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL24702557 0.89 L3MBTL1 (0.41) L3MBTL1KDM4EATMKMT2AMAPT
SCHEMBL20226307 0.89 MAPT (0.38) L3MBTL1KDM4EATMKMT2AMAPT
SCHEMBL2754625 0.89 L3MBTL1 (0.47) L3MBTL1KDM4EATMKMT2AMAPT
SCHEMBL19998012 0.88 L3MBTL1 (0.40) L3MBTL1KDM4EATMKMT2AMAPT
SCHEMBL17445340 0.88 L3MBTL1 (0.40) L3MBTL1KDM4EATMKMT2AMAPT
SCHEMBL18926283 0.87 L3MBTL1 (0.41) L3MBTL1KDM4EATMKMT2AMAPT
SCHEMBL19769788 0.86 L3MBTL1 (0.45) L3MBTL1KDM4EATMKMT2AMAPT
SCHEMBL19769789 0.86 L3MBTL1 (0.45) L3MBTL1KDM4EATMKMT2AMAPT
SCHEMBL15073463 0.86 L3MBTL1 (0.45) L3MBTL1KDM4EATMKMT2AMAPT
SCHEMBL12175712 0.86 MEN1 (0.42) L3MBTL1KDM4EATMKMT2AMAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230134350-A1 ORGANIC COMPOUND AND ORGANIC ELECTROLUMINESCENCE DEVICE USING THE SAME LUMINESCENCE TECHNOLOGY CORP. (TW) 2023-05-04 US disclosed
US-20230134350-A1 ORGANIC COMPOUND AND ORGANIC ELECTROLUMINESCENCE DEVICE USING THE SAME LUMINESCENCE TECHNOLOGY CORP. (TW) 2023-05-04 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230134350-A1 ORGANIC COMPOUND AND ORGANIC ELECTROLUMINESCENCE DEVICE USING THE SAME OR10J3, ODC1, OTC L3MBTL1 1713/4885KDM4E 2552/4885ATM 3693/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.